3: Initial statement of beneficial ownership of securities-Director Zhang Hong
424B3: Prospectus
8-K: Current report
8-K: Current report
424B3: Prospectus
424B3: Prospectus
8-K: Current report
424B3: Prospectus
10-Q: Quarterly report
8-K: Current report
Estrella Immunopharma | 8-K: Current report
Estrella Immunopharma | 424B3: Prospectus
Estrella Immunopharma | 8-K: Current report
Estrella Immunopharma | 424B3: Prospectus
Estrella Immunopharma | 8-K: Current report
Estrella Immunopharma | 424B3: Prospectus
Estrella Immunopharma | 10-Q: Q2 2024 Earnings Report
Estrella Immunopharma | 424B3: Prospectus
Estrella Immunopharma | 8-K: Current report
Estrella Immunopharma | 8-K: Current report
No Data